Quick Answer
Astrana Health, Inc. reported Total Revenue of $3.18 billion for fiscal year 2025.
Astrana Health, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $3.18B +56.4% |
$2.03B +46.7% |
$1.39B +21.2% |
$1.14B +47.8% |
$773.91M +12.6% |
$687.18M +22.6% |
| Revenue (ASC 606) | $3.18B +56.4% |
$2.03B +46.7% |
$1.39B +21.2% |
$1.14B +47.8% |
$773.91M +12.6% |
$687.18M +22.6% |
| Net Income | $22.49M -47.9% |
$43.15M -28.9% |
$60.72M +34.4% |
$45.17M -34.5% |
$68.92M +82.0% |
$37.87M +168.2% |
| Diluted EPS | $0.46 -48.9% |
$0.90 -30.2% |
$1.29 +30.3% |
$0.99 -34.9% |
$1.52 +50.5% |
$1.01 +159.0% |
| Total Assets | $2.22B +63.8% |
$1.35B +45.2% |
$933.36M -3.4% |
$966.21M +13.4% |
$852.36M +4.3% |
$817.49M +12.2% |
| Cash and Equivalents | $429.47M +48.9% |
$288.45M -1.8% |
$293.81M +2.0% |
$288.03M +23.6% |
$233.10M +20.5% |
$193.47M +87.5% |
| Long-Term Debt | $990.90M +133.0% |
$425.30M +64.2% |
$258.94M +27.3% |
$203.39M +11.2% |
$182.92M -20.5% |
$230.21M -0.8% |
| Stockholders Equity | $779.29M +9.3% |
$712.72M +16.0% |
$614.22M +13.2% |
$542.56M +19.4% |
$454.55M +37.4% |
$330.82M +72.7% |
| Operating Income | $78.53M -12.1% |
$89.35M +5.6% |
$84.61M -18.8% |
$104.27M +6.2% |
$98.18M +22.0% |
$80.50M +148.3% |
| Gross Profit | — | — | — | — | — | — |
| Shares Outstanding | 48.89M +2.0% |
47.93M +9486.0% |
500,000 | — | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $956.05M | +99.7% | +46.0% |
| Revenue (ASC 606) | September 30, 2025 | $956.05M | +99.7% | +46.0% |
| Net Income | September 30, 2025 | $373.0K | -97.7% | -96.0% |
| Diluted EPS | September 30, 2025 | $0.01 | -97.0% | -94.7% |
| Total Assets | September 30, 2025 | $2.24B | +74.0% | +55.1% |
| Cash and Equivalents | September 30, 2025 | $462.23M | +32.8% | +36.1% |
| Long-Term Debt | September 30, 2025 | $1.00B | +136.8% | +149.8% |
| Stockholders Equity | September 30, 2025 | $775.54M | +10.1% | +1.3% |
| Operating Income | September 30, 2025 | $19.21M | -32.4% | -5.6% |
| Gross Profit | October 31, 2013 | $464.6K | +179.6% | +105.0% |
| Shares Outstanding | September 30, 2023 | 46.61M | +3.8% | +0.1% |
- Astrana Health, Inc. reported Total Revenue of $3.18 billion for fiscal year 2025.
- Astrana Health, Inc. showed an increase of +56.4% in Total Revenue compared to the prior fiscal year.
- Astrana Health, Inc. reported Revenue (ASC 606) of $3.18 billion for fiscal year 2025.
- Astrana Health, Inc. showed an increase of +56.4% in Revenue (ASC 606) compared to the prior fiscal year.
- Astrana Health, Inc. reported Net Income of $22.49 million for fiscal year 2025.
- Astrana Health, Inc. showed a decrease of -47.9% in Net Income compared to the prior fiscal year.
- Astrana Health, Inc. reported Diluted EPS of $0.46 per share for fiscal year 2025.
- Astrana Health, Inc. showed a decrease of -48.9% in Diluted EPS compared to the prior fiscal year.
- Astrana Health, Inc. reported Total Assets of $2.22 billion for fiscal year 2025.
- Astrana Health, Inc. showed an increase of +63.8% in Total Assets compared to the prior fiscal year.
- Astrana Health, Inc. reported Cash and Equivalents of $429.47 million for fiscal year 2025.
- Astrana Health, Inc. showed an increase of +48.9% in Cash and Equivalents compared to the prior fiscal year.
- Astrana Health, Inc. reported Long-Term Debt of $990.90 million for fiscal year 2025.
- Astrana Health, Inc. showed an increase of +133.0% in Long-Term Debt compared to the prior fiscal year.
- Astrana Health, Inc. reported Stockholders Equity of $779.29 million for fiscal year 2025.
- Astrana Health, Inc. showed an increase of +9.3% in Stockholders Equity compared to the prior fiscal year.
- Astrana Health, Inc. reported Operating Income of $78.53 million for fiscal year 2025.
- Astrana Health, Inc. showed a decrease of -12.1% in Operating Income compared to the prior fiscal year.
- Astrana Health, Inc. reported Gross Profit of $1.41 million for fiscal year 2014.
- Astrana Health, Inc. showed a decrease of -3.6% in Gross Profit compared to the prior fiscal year.
- Astrana Health, Inc. reported Shares Outstanding of 48.89 million shares for fiscal year 2025.
- Astrana Health, Inc. showed an increase of +2.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: